Page last updated: 2024-08-25

doripenem and Bacterial Disease

doripenem has been researched along with Bacterial Disease in 38 studies

Research

Studies (38)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	25 (65.79)	29.6817
2010's	13 (34.21)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA	1
Guzek, A; Korzeniewski, K; Nitsch-Osuch, A; Prokop, E; Rybicki, Z	1
Fujita, T; Hata, H; Hieda, M; Hori, Y; Kobayashi, J; Murata, Y; Nakajima, S; Nakatani, T; Sata, M; Sato, T; Seguchi, O; Sunami, H; Wada, K; Watanabe, T; Yanase, M	1
Igarashi, Y; Inui, K; Ohara, H; Ryozawa, S; Tazuma, S; Tsuyuguchi, T	1
Ishibashi, T; Kubota, R; Matsuo, Y; Wajima, T	1
Li, Y; Liu, J; Lv, Y; Xue, F; Zhang, J; Zheng, B	1
Friedland, I; Jasovich, A; Jiang, J; Kaniga, K; Lucasti, C; Umeh, O	1
Chimura, T; Hirayama, T; Murayama, K; Numazaki, M; Ogawa, H	1
Hedge, DD	1
Keam, SJ	1
Porath, AD	1
French, GL	1
Lancaster, JW; Matthews, SJ	1
Citron, DM; Goldstein, EJ	1
Ambrose, PG; Andes, DR; Bhavnani, SM; Van Wart, SA	1
Livermore, DM	1
Dedhia, HV; McKnight, R	1
Friedland, I; Ketter, N; Redman, R; Rubinstein, E; Zhanel, GG	1
Guery, BP	1
Danishuddin, M; Khan, AU; Shakil, S	1
Overturf, GD	1
Lin, R; Nandy, P; Samtani, MN	1
Dubreuil, L; Jean-Pierre, H; Mahieux, S; Marchandin, H; Miara, A; Muller-Serieys, C; Neut, C; Soussy, CJ	1
Cantón, R; García, A; Gimeno, C; Gobernado, M	1
Buron, JA; Cerrato, SG; Garau, J; Rello, J; Rodriguez, JA; Rossolini, GM; Zaragoza, R	1
Chahine, EB; Ferrill, MJ; Poulakos, MN	1
Botha, F; Burgmann, H; Donath, O; Illievich, UM; Müller, M; Poeppl, W; Wurm, G; Zeitlinger, M	1
Ichikawa, M; Kurokawa, M; Nannya, Y; Narukawa, K; Toya, T	1
Biedenbach, DJ; Fritsche, TR; Huynh, HK; Jones, RN; Sader, HS	1
Biedenbach, DJ; Huynh, HK; Jones, RN	1
Ambrose, PG; Bhavnani, SM; Cirincione, BB; Hammel, JP; Wikler, MA	1
Anderson, DL	1
Dilay, L; Hoban, DJ; Karlowsky, JA; Noreddin, AM; Rubinstein, E; Thomson, K; Wiebe, R; Zhanel, GG	1
Katsube, T; Yamano, Y; Yano, Y	1
Lister, PD	1
Hayasaki, Y; Hua, YX; Izumi, K; Mikamo, H; Sato, Y; Tamaya, T	1

Reviews

15 review(s) available for doripenem and Bacterial Disease

Article	Year
Doripenem: a review of its use in the treatment of bacterial infections. Drugs, 2008, Volume: 68, Issue:14 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Humans; Kidney Diseases; Tissue Distribution	2008
What's new and not so new on the antimicrobial horizon? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14 Suppl 6 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Pyrimidines; Research	2008
Doripenem monohydrate, a broad-spectrum carbapenem antibiotic. Clinical therapeutics, 2009, Volume: 31, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests	2009
Activity of a novel carbapenem, doripenem, against anaerobic pathogens. Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Doripenem; Humans; Microbial Sensitivity Tests; Rats	2009
Doripenem: antimicrobial profile and clinical potential. Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4 Topics: Bacteria; Bacterial Infections; Carbapenems; Doripenem; Humans	2009
Doripenem: position in clinical practice. Expert review of anti-infective therapy, 2009, Volume: 7, Issue:5 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Cross Infection; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas Infections	2009
Overview of seizure-inducing potential of doripenem. Drug safety, 2009, Volume: 32, Issue:9 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Humans; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Seizures; Young Adult	2009
[Doripenem: need for a new carbapenem]. Medecine et maladies infectieuses, 2009, Volume: 39, Issue:12 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Burkholderia cepacia; Carbapenems; Clinical Trials as Topic; Cross Infection; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Humans; Nervous System Diseases; Peritonitis; Pneumonia, Bacterial; Pseudomonas aeruginosa; Urinary Tract Infections	2009
Doripenem versus bacteria: an emerging battleground. Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:5 Topics: Animals; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Humans	2009
Doripenem: an early look at a carbapenem not yet approved for pediatrics. The Pediatric infectious disease journal, 2010, Volume: 29, Issue:2 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Humans; Microbial Sensitivity Tests	2010
Doripenem: a new carbapenem antibiotic. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Dec-01, Volume: 67, Issue:23 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Formularies, Hospital as Topic; Humans	2010
Doripenem: S 4661. Drugs in R&D, 2003, Volume: 4, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Stability; Humans	2003
Doripenem. Drugs of today (Barcelona, Spain : 1998), 2006, Volume: 42, Issue:6 Topics: Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Clinical Trials, Phase III as Topic; Doripenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic	2006
Comparative review of the carbapenems. Drugs, 2007, Volume: 67, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Humans; Imipenem; Meropenem; Thienamycins	2007
Carbapenems in the USA: focus on doripenem. Expert review of anti-infective therapy, 2007, Volume: 5, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Structure-Activity Relationship; Thienamycins; United States	2007

Trials

6 trial(s) available for doripenem and Bacterial Disease

Article	Year
Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem/cilastatin as comparator. Journal of gastroenterology, 2015, Volume: 50, Issue:2 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Body Temperature; C-Reactive Protein; Carbapenems; Cholangitis; Cholecystitis, Acute; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Young Adult	2015
Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study. Clinical therapeutics, 2008, Volume: 30, Issue:5 Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins	2008
[Clinical examination of doripenem for infectious diseases in gynecological and associated fields]. The Japanese journal of antibiotics, 2008, Volume: 61, Issue:2 Topics: Bacterial Infections; Carbapenems; Doripenem; Female; Genital Diseases, Female; Humans; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Infectious; Puerperal Infection; Treatment Outcome	2008
Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bayes Theorem; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nonlinear Dynamics; Pneumonia, Bacterial; Pyelonephritis; Renal Insufficiency; Urinary Tract Infections; Young Adult	2010
A comparative analysis of meropenem and doripenem in febrile patients with hematologic malignancies: a single-center retrospective study. Japanese journal of infectious diseases, 2012, Volume: 65, Issue:3 Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Female; Fever; Hematologic Neoplasms; Humans; Male; Meropenem; Middle Aged; Retrospective Studies; Risk Factors; Thienamycins; Treatment Outcome	2012
Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:9 Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Models, Statistical; Monte Carlo Method	2005

Other Studies

17 other study(ies) available for doripenem and Bacterial Disease

Article	Year
In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Diabetic Foot; Doripenem; Humans; Microbial Sensitivity Tests	2008
In vitro sensitivity of Acinetobacter baumannii and Pseudomonas aeruginosa to carbapenems among intensive care unit patients. Advances in experimental medicine and biology, 2013, Volume: 788 Topics: Acinetobacter baumannii; Bacterial Infections; Carbapenems; Doripenem; Electrophoresis, Gel, Pulsed-Field; Europe; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sensitivity and Specificity; Species Specificity; Thienamycins; United States; United States Food and Drug Administration	2013
Importance of early appropriate intervention including antibiotics and wound care for device-related infection in patients with left ventricular assist device. Transplantation proceedings, 2014, Volume: 46, Issue:3 Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Carbapenems; Doripenem; Female; Heart-Assist Devices; Humans; Male; Retrospective Studies; Teicoplanin; Wounds and Injuries	2014
Population pharmacokinetics of doripenem in Japanese subjects and Monte-Carlo simulation for patients with renal impairment. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Carbapenems; Computer Simulation; Doripenem; Humans; Japan; Middle Aged; Models, Biological; Models, Statistical; Monte Carlo Method; Renal Insufficiency; Young Adult	2015
Antimicrobial resistance surveillance of doripenem in China. The Journal of antibiotics, 2015, Volume: 68, Issue:8 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; China; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Epidemiological Monitoring; Hospitals; Humans; Microbial Sensitivity Tests; Prevalence; Pseudomonas aeruginosa	2015
Doripenem: a new carbapenem. South Dakota medicine : the journal of the South Dakota State Medical Association, 2008, Volume: 61, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Humans	2008
Lucasti et al in the May 2008 issue of Clinical Therapeutics. Clinical therapeutics, 2008, Volume: 30, Issue:10 Topics: Abdominal Abscess; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Humans; Imipenem; Meropenem; Thienamycins	2008
Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patients. Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Computer Simulation; Critical Illness; Doripenem; Female; Humans; Mice	2009
[Activity of doripenem against anaerobic bacteria]. Pathologie-biologie, 2011, Volume: 59, Issue:2 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Humans; Imipenem; Microbial Sensitivity Tests	2011
[Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2010, Volume: 23, Issue:3 Topics: Acinetobacter Infections; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas Infections; Spain; Thienamycins	2010
Nosocomial infections: new therapeutic alternatives. Expert review of anti-infective therapy, 2010, Volume: 8, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic	2010
Penetration of doripenem in human brain: an observational microdialysis study in patients with acute brain injury. International journal of antimicrobial agents, 2012, Volume: 39, Issue:4 Topics: Aged; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Brain; Brain Injuries; Carbapenems; Doripenem; Female; Humans; Male; Microbial Sensitivity Tests; Microdialysis; Middle Aged; Plasma; Time Factors	2012
Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations. The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:1 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Culture Media; Doripenem; Enterobacteriaceae; Enterococcus; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Quality Control; Respiratory Tract Infections	2004
Activities of doripenem (S-4661) against drug-resistant clinical pathogens. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8 Topics: Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Resistance, Bacterial; Genotype; Gram-Negative Bacteria; Humans; Phenotype	2004
Pharmacokinetic-pharmacodynamic modeling and simulation for in vivo bactericidal effect in murine infection model. Journal of pharmaceutical sciences, 2008, Volume: 97, Issue:4 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Carbapenems; Cilastatin; Disease Models, Animal; Doripenem; Female; Imipenem; Meropenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Models, Biological; Thienamycins	2008
Doripenem (Doribax)--a new parenteral carbapenem. The Medical letter on drugs and therapeutics, 2008, Jan-28, Volume: 50, Issue:1278 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Administration Schedule; Drug Interactions; Humans; Infusions, Intravenous; Pneumonia, Ventilator-Associated; Treatment Outcome; Urinary Tract Infections	2008
In vitro and in vivo antibacterial activities of a new injectable carbapenem, S-4661, against gynaecological pathogens. The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Rats; Uterine Diseases	2000